Skip to main content
medichelpline
Back to Drug Index
General MedicationsINJECTIONStandard

GRANIX

TBO-FILGRASTIM

Standard Dose
300MCG/0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview GRANIX is listed in Drugs@FDA under application 125294 (BLA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient TBO-FILGRASTIM Form and strength INJECTABLE; INJECTION - 300MCG/0.5ML Sponsor SICOR BIOTECH Submission history Latest submission status date: 2023-11-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRANIX is listed in Drugs@FDA under application 125294 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TBO-FILGRASTIM Form and strength INJECTABLE; INJECTION - 300MCG/0.5ML Sponsor SICOR BIOTECH Submission history Latest submission status date: 2023-11-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.